Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - memantine hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease.

Singapore - English - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - memantine hcl - tablet, film coated - 10 mg - memantine hcl 10 mg

European Union - English - EMA (European Medicines Agency)

h. lundbeck a/s - memantine hydrochloride - alzheimer disease - other anti-dementia drugs - treatment of patients with moderate to severe alzheimer's disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - memantine hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - memantine hydrochloride 10mg; memantine hydrochloride 10mg - film coated tablet - 10 mg - active: memantine hydrochloride 10mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate methacrylic acid - ethyl acrylate copolymer microcrystalline cellulose polysorbate 80 purified talc   purified water simeticone sodium laurilsulfate triacetin active: memantine hydrochloride 10mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose titanium dioxide - treatment of patients with moderate to severe alzheimer's disease

Israel - English - Ministry of Health

lundbeck israel ltd. - memantine hydrochloride - film coated tablets - memantine hydrochloride 10 mg - memantine - memantine - treatment of patient with moderate to severe alzheimer's disease.

Israel - English - Ministry of Health

lundbeck israel ltd. - memantine hydrochloride - film coated tablets - memantine hydrochloride 20 mg - memantine - memantine - treatment of patient with moderate to severe alzheimer's disease.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - memantine hydrochloride - oral solution - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - memantine hydrochloride - tablet - 20mg